Phase 1 Pharmacokinetics of Intravenous Nexium in Children

Completed · Phase 1

Conditions studied: Pharmacokinetics

In brief

The purpose of this research study is to evaluate how much of repeated once daily intravenous (IV, meaning through a vein) doses of esomeprazole gets into the bloodstream of hospitalized children aged 0-17 years old that require acid suppression therapy.

Key facts

Study ID
NCT00474019
Run by
AstraZeneca
People needed
42
Starts
2007-10-01
Expected to finish
2009-10-01
Last updated by the study team
2010-12-03

Who can join

Age: any, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.